Novacor France
FranceFDA applicant, unverified
- Devices
- 1
What Novacor France makes
Novacor France manufactures the DIASYS INTEGRA II, a medical device designed for continuous monitoring of blood glucose levels in patients, providing real-time data for diabetes management.
The DIASYS INTEGRA II is classified as a Class II device under FDA regulations and is listed in the FDA’s 510(k) registry. The company is based in the United States.
Catalogue
Diasys Integra Ii Ref K042109
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Novacor France have in the registry?
The registry currently lists 1 device for Novacor France. Devices recorded under merged duplicate company entries are counted once.
Which registries list Novacor France's devices?
Among its 1 most recently registered device, Novacor France has devices listed in FDA 510(k) (1 device).
What risk classes do Novacor France's devices fall under?
Among its 1 most recently registered device, the classes recorded for Novacor France's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Novacor France in the registry?
The most recently registered devices listed for Novacor France include DIASYS INTEGRA II.